tradingkey.logo

MDNA Life Sciences Units (Proposed)

MDLS
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM

MDNA Life Sciences Units (Proposed)

0.0000.00%

More Details of MDNA Life Sciences Units (Proposed) Company

MDNA Life Sciences Inc is a United States-based company. It develops and commercializes diagnostic tests for the detection of disease in humans. The Company's products include mitochondrial deoxyribonucleic acid (DNA) test (MDNA Test) for prostate cancer detection, mitomics test for human chorosomes, and mitomic DNA test for non-invasive uterine fibrocarcinoma (NFT). Its products are used to detect diseases such as prostate cancer, endometriosis, skin cancer and UV damage.

MDNA Life Sciences Units (Proposed) Info

Ticker SymbolMDLS
Company nameMDNA Life Sciences Inc
IPO date- -
CEOMitton (Christopher C)
Number of employees12
Security typeUnit
Fiscal year-end- -
Address2054 Vista Parkway,
CityWEST PALM BEACH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33411
Phone18443216362
Websitehttps://mdnalifesciences.com/
Ticker SymbolMDLS
IPO date- -
CEOMitton (Christopher C)

Company Executives of MDNA Life Sciences Units (Proposed)

Name
Name/Position
Position
Shareholding
Change
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Harry Smart
Mr. Harry Smart
Chairman of the Board
Chairman of the Board
--
--
Dr. Robert Thayer, Ph.D.
Dr. Robert Thayer, Ph.D.
Independent Director
Independent Director
--
--
Mr. Christopher Hill
Mr. Christopher Hill
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Harry Smart
Mr. Harry Smart
Chairman of the Board
Chairman of the Board
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%

Institutional Shareholding

Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
No Data

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI